Hypertension, Vol 24, 679-685, Copyright © 1994 by American Heart Association
A Anwar and P Delafontaine
Insulin-like growth factor-I (IGF-I) is an endocrine and
autocrine/paracrine growth factor. Recently, we have demonstrated that
interrenal aortic coarctation in the rat increases IGF-I mRNA levels in the
thoracic aorta, consistent with a role for this mitogen in hypertensive
vascular remodeling. The effects of IGF-I are modulated by several IGF
binding proteins including IGFBP-3, the main circulating carrier of IGF-I,
and IGFBP-4, the main IGF binding protein produced by vascular smooth
muscle cells in vitro. To obtain insights into the regulation of IGF-I and
more specifically to study potential changes in IGF binding proteins in
high-renin hypertension, we studied male Sprague-Dawley rats that had
undergone abdominal aortic coarctation. Compared with sham-operated rats,
the study rats showed a rapid increase in IGFBP-4 mRNA levels in the
hypertensive (thoracic) aorta, reaching a plateau at 3 days (2.5-fold
increase) and persisting for at least 14 days. In striking contrast,
IGFBP-4 mRNA decreased slightly in the normotensive (abdominal) aorta at 14
days. IGFBP-3 mRNA levels did not change in either vascular bed after
coarctation. Study of hepatic tissue indicated that in coarcted rats
IGFBP-4 and IGFBP-3 mRNA levels decreased transiently (approximately 50% at
7 days compared with sham). Circulating IGF-I in coarcted animals decreased
slightly (P = .08), and Western ligand analysis indicated that circulating
levels of IGF binding proteins were not altered.(ABSTRACT TRUNCATED AT 250
WORDS)
ARTICLES
Hypertension increases insulin-like growth factor binding protein-4 mRNA levels in rat aorta
Department of Medicine, Emory University, Atlanta, Ga 30322.
This article has been cited by other articles:
![]() |
P. Delafontaine, Y.-H. Song, and Y. Li Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 435 - 444. [Abstract] [Full Text] |
||||
![]() |
M. Zhang, E. P. Smith, H. Kuroda, W. Banach, S. D. Chernausek, and J. A. Fagin Targeted Expression of a Protease-resistant IGFBP-4 Mutant in Smooth Muscle of Transgenic Mice Results in IGFBP-4 Stabilization and Smooth Muscle Hypotrophy J. Biol. Chem., June 7, 2002; 277(24): 21285 - 21290. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Berk Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms Physiol Rev, July 1, 2001; 81(3): 999 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vecchione, S. Colella, L. Fratta, M. T. Gentile, G. Selvetella, G. Frati, B. Trimarco, and G. Lembo Impaired Insulin-Like Growth Factor I Vasorelaxant Effects in Hypertension Hypertension, June 1, 2001; 37(6): 1480 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Anwar, A. A. Zahid, L. Phillips, and P. Delafontaine Insulin-Like Growth Factor Binding Protein-4 Expression Is Decreased by Angiotensin II and Thrombin in Rat Aortic Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 370 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gustafsson, P. Andersson, Y. Chen, J. O. Magnusson, and H. J. Arnqvist Interaction of angiotensin II and the insulin-like growth factor system in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H499 - H507. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Scheidegger, R. W. James, and P. Delafontaine Differential Effects of Low Density Lipoproteins on Insulin-like Growth Factor-1 (IGF-1) and IGF-1 Receptor Expression in Vascular Smooth Muscle Cells J. Biol. Chem., August 25, 2000; 275(35): 26864 - 26869. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |